|
Quotes & Info
|
| SCLN > SEC Filings for SCLN > Form 8-K on 6-Nov-2009 | All Recent SEC Filings |
6-Nov-2009
Amendment or Waiver to Code of Ethics, Financial Statements and Exhi
On November 5, 2009, the Board of Directors of SciClone Pharmaceuticals, Inc. (the "Company") approved amending and restating the Company's Code of Ethics principally to include additional language regarding requiring employees to conduct fair dealing practices and explicitly prohibiting bribery. The full amended and restated Code of Ethics is attached to this Current Report on Form 8-K as Exhibit 14.1 and is incorporated herein by reference in its entirety.
(d) The following exhibits are filed herewith:
|
|